CNTX
Context Therapeutics Inc.
Key Financials
Net Income
$-36123615
↓ 35.2%
Operating Income
$-39702631
↓ 32.7%
Total Liabilities
$8.0M
↑ 180.4%
EPS (Diluted)
$-0.38
↑ 17.4%
Shareholders' Equity
$60.5M
↓ 36.5%
Total Assets
$68.5M
↓ 30.2%
Cash & Equivalents
$66.0M
↓ 30.1%
Operating Cash Flow
$-26385380.00
↓ 81.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 6/26/2026 | View on SEC |
| 4 | 6/26/2026 | View on SEC |
| 4 | 6/26/2026 | View on SEC |
| 4 | 6/26/2026 | View on SEC |
| 4 | 6/26/2026 | View on SEC |
| 4 | 6/26/2026 | View on SEC |
| 8-K | 6/26/2026 | View on SEC |
| 8-K | 6/15/2026 | View on SEC |
| 8-K | 5/18/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CNTX |
| Company Name | Context Therapeutics Inc. |
| CIK | 1842952 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 267-225-7416 |